Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry /

The pharmaceutical industry is in a dire situation: R&D still produces no more drugs than 10 years ago, while costs have quadrupled in the meantime. Little advances have been made in innovation efficiency. Worse yet, drug development times are unacceptably long, possible drug development targets...

Full description

Bibliographic Details
Main Author: Gassmann, Oliver, 1967-
Corporate Author: SpringerLink (Online service)
Other Authors: Zedtwitz, Maximilian von, 1969-, Reepmeyer, Gerrit, 1976-
Format: eBook
Language:English
Published: Berlin ; New York : Springer, [2004]
Subjects:
Online Access:Connect to the full text of this electronic book
Description
Summary:The pharmaceutical industry is in a dire situation: R&D still produces no more drugs than 10 years ago, while costs have quadrupled in the meantime. Little advances have been made in innovation efficiency. Worse yet, drug development times are unacceptably long, possible drug development targets are waning, and national healthcare is tightening the cost squeeze. A predictable and efficient pipeline of drug candidates, coupled with a handful of blockbuster drugs, is considered the Holy Grail of pharmaceutical innovation. In this book, the authors develop a case for mastering pharmaceutical innovation focusing on three leading sources of future pharmaceutical competitiveness: new technologies and techniques, better pipeline management, and stronger integration of external innovation. Illustrated with plenty of real-life cases, this book tells you how to put the principles of leading pharmaceutical innovation into practice.
Physical Description:1 online resource (xi, 178 pages) : illustrations, maps.
Bibliography:Includes bibliographical references (pages [159]-163) and index.
ISBN:9783540247814 (electronic bk.)
3540247815 (electronic bk.)